Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritonavir Dose Reduction in Tipranavir-Treated HIV Patients
NCT00607958Phase 4Completed
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Dec 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tipranavir in human immunodeficiency virus infection (HIV), sponsored by Hospital Universitari Germans Trias i Pujol. Started Dec 2007; status: completed.
02
Drugs
tipranavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00607958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607958.